1. Home
  2. NLSP vs BCML Comparison

NLSP vs BCML Comparison

Compare NLSP & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BCML
  • Stock Information
  • Founded
  • NLSP 2015
  • BCML 2004
  • Country
  • NLSP Switzerland
  • BCML United States
  • Employees
  • NLSP N/A
  • BCML N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • NLSP Health Care
  • BCML Finance
  • Exchange
  • NLSP Nasdaq
  • BCML Nasdaq
  • Market Cap
  • NLSP 12.4M
  • BCML 294.2M
  • IPO Year
  • NLSP 2021
  • BCML N/A
  • Fundamental
  • Price
  • NLSP $2.10
  • BCML $28.19
  • Analyst Decision
  • NLSP
  • BCML
  • Analyst Count
  • NLSP 0
  • BCML 0
  • Target Price
  • NLSP N/A
  • BCML N/A
  • AVG Volume (30 Days)
  • NLSP 269.6K
  • BCML 31.1K
  • Earning Date
  • NLSP 07-22-2025
  • BCML 07-21-2025
  • Dividend Yield
  • NLSP N/A
  • BCML 2.79%
  • EPS Growth
  • NLSP N/A
  • BCML N/A
  • EPS
  • NLSP N/A
  • BCML 2.10
  • Revenue
  • NLSP N/A
  • BCML $95,714,000.00
  • Revenue This Year
  • NLSP N/A
  • BCML $1.24
  • Revenue Next Year
  • NLSP N/A
  • BCML $6.52
  • P/E Ratio
  • NLSP N/A
  • BCML $13.40
  • Revenue Growth
  • NLSP N/A
  • BCML N/A
  • 52 Week Low
  • NLSP $1.30
  • BCML $20.23
  • 52 Week High
  • NLSP $15.59
  • BCML $30.13
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 46.61
  • BCML 63.06
  • Support Level
  • NLSP $2.20
  • BCML $28.32
  • Resistance Level
  • NLSP $3.08
  • BCML $29.46
  • Average True Range (ATR)
  • NLSP 0.25
  • BCML 0.74
  • MACD
  • NLSP -0.06
  • BCML 0.13
  • Stochastic Oscillator
  • NLSP 8.40
  • BCML 78.43

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: